Literature DB >> 19819350

Factors influencing polyautoimmunity in systemic lupus erythematosus.

Adriana Rojas-Villarraga1, Carlos-Enrique Toro, Gerard Espinosa, Yolima Rodríguez-Velosa, Carolina Duarte-Rey, Rubén D Mantilla, Antonio Iglesias-Gamarra, Ricard Cervera, Juan-Manuel Anaya.   

Abstract

OBJECTIVE: Since characterization of the extent to which particular combinations of autoimmune diseases (ADs) occur in excess of that expected by chance may offer new insights into possible common pathophysiological mechanisms, polyautoimmunity (i.e., ADs co-occurring within patients) in systemic lupus erythematosus (SLE) and its associated factors were investigated.
METHODS: This was a cross-sectional study in which 335 consecutive patients with SLE and the history of 22 ADs were investigated. A multivariate analysis was performed. A systematic literature review was done and results were grouped by hierarchical cluster procedure analysis.
RESULTS: There were 136 (41%) SLE patients presenting with at least one other AD. A total of 191 ADs were observed, of which the most frequent were autoimmune thyroid disease (AITD), antiphospholipid syndrome (APS) and Sjögren's syndrome (SS), registered in 60 (18%), 48 (14%) and 47 (14%) cases, respectively. Out of a total number of 1515 SLE patients with polyautoimmunity (1379 reported previously and 136 informed here) there were 77 (5.1%) cases with multiple autoimmune syndrome (i.e., two or more ADs in addition to SLE). Female gender, articular involvement, familial autoimmunity, anti-Ro positivity and patient's origin were risk factors for polyautoimmunity while the presence of anti-RNP antibodies was protective. Four clusters of ADs were found. The most hierarchical one was composed of AITD, APS, SS, and systemic sclerosis.
CONCLUSION: Polyautoimmunity is frequent in SLE, and it is influenced by clinical and immunological features. These findings support that clinically different autoimmune phenotypes might share common susceptibility variants. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19819350     DOI: 10.1016/j.autrev.2009.10.001

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  16 in total

1.  Reproductive immunology: a focus on the role of female sex hormones and other gender-related factors.

Authors:  Elena Peeva
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

2.  The multiple autoimmune syndromes. A clue for the autoimmune tautology.

Authors:  Juan-Manuel Anaya; John Castiblanco; Adriana Rojas-Villarraga; Ricardo Pineda-Tamayo; Roger A Levy; José Gómez-Puerta; Carlos Dias; Ruben D Mantilla; Juan Esteban Gallo; Ricard Cervera; Yehuda Shoenfeld; Mauricio Arcos-Burgos
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

3.  Mesenchymal stem cells ameliorate B-cell-mediated immune responses and increase IL-10-expressing regulatory B cells in an EBI3-dependent manner.

Authors:  Kyung-Ah Cho; Jun-Kyu Lee; Yu-Hee Kim; Minhwa Park; So-Youn Woo; Kyung-Ha Ryu
Journal:  Cell Mol Immunol       Date:  2017-01-02       Impact factor: 11.530

4.  Multiple autoimmune syndromes associated with psoriasis: a rare clinical presentation.

Authors:  Sadia Masood; Sara Sajid; Asif Jafferani; Saadia Tabassum; Sobia Ansar
Journal:  Oman Med J       Date:  2014-03

Review 5.  Evaluation of genetic association between an ITGAM non-synonymous SNP (rs1143679) and multiple autoimmune diseases.

Authors:  Juan-Manuel Anaya; Xana Kim-Howard; Sampath Prahalad; Alejandra Cherñavsky; Carlos Cañas; Adriana Rojas-Villarraga; John Bohnsack; Roland Jonsson; Anne Isine Bolstad; Johan G Brun; Beth Cobb; Kathy L Moser; Judith A James; John B Harley; Swapan K Nath
Journal:  Autoimmun Rev       Date:  2011-08-05       Impact factor: 9.754

6.  Subclinical hypothyroidism is a risk factor for delayed clinical complete response in patients with systemic lupus erythematosus (SLE).

Authors:  Lin Dong; Liu Jia; Xuezhi Hong; Guangliang Chen; Hanyou Mo
Journal:  Int J Clin Exp Med       Date:  2014-09-15

7.  Autoimmune thyroid disease in rheumatoid arthritis: a global perspective.

Authors:  Jorge Cárdenas Roldán; Jenny Amaya-Amaya; Juan Castellanos-de la Hoz; Juliana Giraldo-Villamil; Gladys Montoya-Ortiz; Paola Cruz-Tapias; Adriana Rojas-Villarraga; Rubén D Mantilla; Juan-Manuel Anaya
Journal:  Arthritis       Date:  2012-11-18

8.  Fibronectin molecular status determination useful to differentiate between rheumatoid arthritis and systemic lupus erythematosus patients.

Authors:  Magdalena Przybysz; Krzysztof Borysewicz; Iwona Kątnik-Prastowska
Journal:  Rheumatol Int       Date:  2012-01-04       Impact factor: 2.631

9.  Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis.

Authors:  Marie Hudson; Janet Pope; Michael Mahler; Solène Tatibouet; Russell Steele; Murray Baron; Marvin J Fritzler
Journal:  Arthritis Res Ther       Date:  2012-03-06       Impact factor: 5.156

10.  Introducing polyautoimmunity: secondary autoimmune diseases no longer exist.

Authors:  Adriana Rojas-Villarraga; Jenny Amaya-Amaya; Alberto Rodriguez-Rodriguez; Rubén D Mantilla; Juan-Manuel Anaya
Journal:  Autoimmune Dis       Date:  2012-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.